Sorafenib in liver cancer
HY Woo, J Heo - Expert opinion on pharmacotherapy, 2012 - Taylor & Francis
Introduction: With growing knowledge of the molecular pathway of carcinogenesis, targeted
therapies have become the 'blue ocean'of cancer treatment. sorafenib is an oral multikinase …
therapies have become the 'blue ocean'of cancer treatment. sorafenib is an oral multikinase …
[引用][C] Sorafenib in liver cancer.
HY Woo, J Heo - Expert Opinion on Pharmacotherapy, 2012 - europepmc.org
With growing knowledge of the molecular pathway of carcinogenesis, targeted therapies
have become the'blue ocean'of cancer treatment. sorafenib is an oral multikinase inhibitor …
have become the'blue ocean'of cancer treatment. sorafenib is an oral multikinase inhibitor …
Sorafenib in liver cancer
HY Woo, J Heo - Expert opinion on pharmacotherapy, 2012 - pubmed.ncbi.nlm.nih.gov
Introduction With growing knowledge of the molecular pathway of carcinogenesis, targeted
therapies have become the'blue ocean'of cancer treatment. sorafenib is an oral multikinase …
therapies have become the'blue ocean'of cancer treatment. sorafenib is an oral multikinase …